Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Fulltext:
118827.pdf
Embargo:
until further notice
Size:
1.093Mb
Format:
PDF
Description:
publisher's version
Publication year
2013Author(s)
Source
Nature Genetics, 45, 4, (2013), pp. 371-384ISSN
Related links
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Health Evidence
Urology
Gynaecology
Human Genetics
Former Organization
Epidemiology, Biostatistics & HTA
Journal title
Nature Genetics
Volume
vol. 45
Issue
iss. 4
Page start
p. 371
Page end
p. 384
Subject
NCEBP 1: Molecular epidemiology ONCOL 5: Aetiology, screening and detection; ONCOL 1: Hereditary cancer and cancer-related syndromes; ONCOL 3: Translational research; ONCOL 3: Translational research IGMD 3: Genomic disorders and inherited multi-system disorders; ONCOL 5: Aetiology, screening and detection NCMLS 2: Immune Regulation; ONCOL 3: Translational research IGMD 3: Genomic disorders and inherited multi-system disordersAbstract
TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of multiple cancers. Using the Illumina custom genotyping array iCOGs, we analyzed approximately 480 SNPs at the TERT locus in breast (n = 103,991), ovarian (n = 39,774) and BRCA1 mutation carrier (n = 11,705) cancer cases and controls. Leukocyte telomere measurements were also available for 53,724 participants. Most associations cluster into three independent peaks. The minor allele at the peak 1 SNP rs2736108 associates with longer telomeres (P = 5.8 x 10(-7)), lower risks for estrogen receptor (ER)-negative (P = 1.0 x 10(-8)) and BRCA1 mutation carrier (P = 1.1 x 10(-5)) breast cancers and altered promoter assay signal. The minor allele at the peak 2 SNP rs7705526 associates with longer telomeres (P = 2.3 x 10(-14)), higher risk of low-malignant-potential ovarian cancer (P = 1.3 x 10(-15)) and greater promoter activity. The minor alleles at the peak 3 SNPs rs10069690 and rs2242652 increase ER-negative (P = 1.2 x 10(-12)) and BRCA1 mutation carrier (P = 1.6 x 10(-14)) breast and invasive ovarian (P = 1.3 x 10(-11)) cancer risks but not via altered telomere length. The cancer risk alleles of rs2242652 and rs10069690, respectively, increase silencing and generate a truncated TERT splice variant.
This item appears in the following Collection(s)
- Academic publications [203856]
- Electronic publications [102309]
- Faculty of Medical Sciences [80326]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.